Association between mammographic density and basal-like and luminal A breast cancer subtypes

Breast Cancer Research

Volumn 15, Issue 5, 2013, Pages

  Razzaghi, Hilda ^a,e   Troester, Melissa A ^a,b   Gierach, Gretchen L ^c   Olshan, Andrew F ^a,b   Yankaskas, Bonnie C ^d   Millikan, Robert C ^a  

^a IL   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Basal like; Breast cancer; Epidemiology; Mammographic density; Subtypes

Indexed keywords

CYTOKERATIN 5; CYTOKERATIN 6; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; TUMOR MARKER;

ARTICLE; BASAL LIKE BREAST CANCER; BREAST CANCER; CANCER REGISTRY; CANCER SCREENING; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUMINAL A BREAST CANCER; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MAMMOGRAPHY SYSTEM; PROTEIN EXPRESSION; RISK; ADULT; AGED; BREAST DENSITY; CANCER RISK; DISEASE ASSOCIATION; RISK ASSESSMENT; TRIPLE NEGATIVE BREAST CANCER; TUMOR CLASSIFICATION; BASAL CELL CARCINOMA; BREAST TUMOR; CASE CONTROL STUDY; CONGENITAL MALFORMATION; MAMMARY GLAND; MAMMOGRAPHIC DENSITY; METABOLISM; MIDDLE AGED; PATHOLOGY; REGISTER;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MAMMARY GLANDS, HUMAN; MIDDLE AGED; NEOPLASMS, BASAL CELL; ODDS RATIO; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REGISTRIES; RISK; TUMOR MARKERS, BIOLOGICAL;

EID: 84883294740     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3470     Document Type: Article

References (76)

1. Perou CM, Sorlie T, Eisen MB, Van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D. Molecular portraits of human breast tumours. Nature 2000, 406:747-752. 10.1038/35021093, 10963602.
2. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, Van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Lonning PE, Borresen-Dale AL. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001, 98:10869-10874. 10.1073/pnas.191367098, 58566, 11553815.
3. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J, Perou CM, Lonning PE, Brown PO, Borresen-Dale AL, Botstein D. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 2003, 100:8418-8423. 10.1073/pnas.0932692100, 166244, 12829800.
4. Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, Smith LV, Labbok MH, Geradts J, Bensen JT, Jackson S, Nyante S, Livasy C, Carey L, Earp HS, Perou CM. Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 2008, 109:123-139. 10.1007/s10549-007-9632-6, 2443103, 17578664.
5. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006, 295:2492-2502. 10.1001/jama.295.21.2492, 16757721.
6. Sorlie T. Molecular portraits of breast cancer: tumour subtypes as distinct disease entities. Eur J Cancer 2004, 40:2667-2675. 10.1016/j.ejca.2004.08.021, 15571950.
7. Kwan ML, Kushi LH, Weltzien E, Maring B, Kutner SE, Fulton RS, Lee MM, Ambrosone CB, Caan BJ. Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res 2009, 11:R31. 10.1186/bcr2261, 2716499, 19463150.
8. Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Wactawski-Wende J, Kuller LH, Adams-Campbell LL, Lane D, Stefanick ML, Vitolins M, Kabat GC, Rohan TE, Li CI. Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. J Natl Cancer Inst 2011, 103:470-477. 10.1093/jnci/djr030, 3057984, 21346227.
9. Yang XR, Pfeiffer RM, Garcia-Closas M, Rimm DL, Lissowska J, Brinton LA, Peplonska B, Hewitt SM, Cartun RW, Mandich D, Sasano H, Evans DB, Sutter TR, Sherman ME. Hormonal markers in breast cancer: coexpression, relationship with pathologic characteristics, and risk factor associations in a population-based study. Cancer Res 2007, 67:10608-10617. 10.1158/0008-5472.CAN-07-2142, 17968031.
10. Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, Gaudet M, Schmidt MK, Broeks A, Cox A, Fasching PA, Hein R, Spurdle AB, Blows F, Driver K, Flesch-Janys D, Heinz J, Sinn P, Vrieling A, Heikkinen T, Aittomaki K, Heikkila P, Blomqvist C, Lissowska J, Peplonska B, Chanock S, Figueroa J, Brinton L, Hall P, Czene K, et al. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst 2011, 103:250-263. 10.1093/jnci/djq526, 3107570, 21191117.
11. Broeks A, Schmidt MK, Sherman ME, Couch FJ, Hopper JL, Dite GS, Apicella C, Smith LD, Hammet F, Southey MC, Van't Veer LJ, de Groot R, Smit VT, Fasching PA, Beckmann MW, Jud S, Ekici AB, Hartmann A, Hein A, Schulz-Wendtland R, Burwinkel B, Marme F, Schneeweiss A, Sinn HP, Sohn C, Tchatchou S, Bojesen SE, NOrdestgaard BG, Flyger H, Orsted DD, et al. Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet 2011, 20:3289-3303. 10.1093/hmg/ddr228, 3140824, 21596841.
12. Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Stefanick ML, Wactawski-Wende J, Kuller LH, Adams-Campbell LL, Lane D, Vitolins M, Kabat GC, Rohan TE, Li CI. Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer. Cancer Epidemiol Biomarkers Prev 2011, 20:454-463. 10.1158/1055-9965.EPI-10-0974, 3064558, 21364029.
13. Phipps AI, Buist DS, Malone KE, Barlow WE, Porter PL, Kerlikowske K, Li CI. Reproductive history and risk of three breast cancer subtypes defined by three biomarkers. Cancer Causes Control 2011, 22:399-405. 10.1007/s10552-010-9709-0, 3042513, 21184265.
14. Ma H, Wang Y, Sullivan-Halley J, Weiss L, Marchbanks PA, Spirtas R, Ursin G, Burkman RT, Simon MS, Malone KE, Strom BL, McDonald JA, Press MF, Berstein L. Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study. Cancer Res 2010, 70:575-587. 10.1158/0008-5472.CAN-09-3460, 2807992, 20068186.
15. Bertucci F, Finetti P, Cervera N, Charafe Jauffret E, Buttarelli M, Jacquemier J, Chaffanet M, Maraninchi D, Viens P, Birnbaum D. How different are luminal A and basal breast cancers?. Int J Cancer 2009, 124:1338-1348. 10.1002/ijc.24055, 19058218.
16. Reis Filho JS, Tutt ANJ. Triple negative tumours: a critical review. Histopathology 2008, 52:108-118.
17. McCormack VA, dos Santos SI. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006, 15:1159-1169. 10.1158/1055-9965.EPI-06-0034, 16775176.
18. Vachon CM, Brandt KR, Ghosh K, Scott CG, Maloney SD, Carston MJ, Pankratz VS, Sellers TA. Mammographic breast density as a general marker of breast cancer risk. Cancer Epidemiol Biomarkers Prev 2007, 16:43-49. 10.1158/1055-9965.EPI-06-0738, 17220330.
19. Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, Lockwood GA, Tritchler DL, Yaffe MJ. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 1995, 87:670-675. 10.1093/jnci/87.9.670, 7752271.
20. Ziv E, Shepherd J, Smith-Bindman R, Kerlikowske K. Mammographic breast density and family history of breast cancer. J Natl Cancer Inst 2003, 95:556-558. 10.1093/jnci/95.7.556, 12671024.
21. Boyd NF, Lockwood GA, Martin LJ, Knight JA, Byng JW, Yaffe MJ, Tritchler DL. Mammographic densities and breast cancer risk. Breast Dis 1998, 10:113-126.
22. Ursin G, Ma H, Wu AH, Bernstein L, Salane M, Parisky YR, Astrahan M, Siozon CC, Pike MC. Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev 2003, 12:332-338.
23. Maskarinec G, Pagano I, Lurie G, Wilkens LR, Kolonel LN. Mammographic density and breast cancer risk: the multiethnic cohort study. Am J Epidemiol 2005, 162:743-752. 10.1093/aje/kwi270, 16150892.
24. Brisson J, Merletti F, Sadowsky NL, Twaddle JA, Morrison AS, Cole P. Mammographic features of the breast and breast cancer risk. Am J Epidemiol 1982, 115:428-437.
25. Boyd NF, Martin LJ, Yaffe MJ, Minkin S. Mammographic density and breast cancer risk: current understanding and future prospects. Breast Cancer Res 2011, 13:223. 10.1186/bcr2942, 3326547, 22114898.
26. Ma H, Luo J, Press MF, Wang Y, Bernstein L, Ursin G. Is there a difference in the association between percent mammographic density and subtypes of breast cancer? Luminal A and triple-negative breast cancer. Cancer Epidemiol Biomarkers Prev 2009, 18:479-485. 10.1158/1055-9965.EPI-08-0805, 19190139.
27. Ziv E, Tice J, Smith-Bindman R, Shepherd J, Cummings S, Kerlikowske K. Mammographic density and estrogen receptor status of breast cancer. Cancer Epidemiol Biomarkers Prev 2004, 13:2090-2095.
28. Olsen AH, Bihrmann K, Jensen MB, Vejborg I, Lynge E. Breast density and outcome of mammography screening: a cohort study. Br J Cancer 2009, 100:1205-1208. 10.1038/sj.bjc.6604989, 2669986, 19293800.
29. Yaghjyan L, Colditz GA, Collins LC, Schnitt SJ, Rosner B, Vachon C, Tamimi RM. Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. J Natl Cancer Inst 2011, 103:1179-1189. 10.1093/jnci/djr225, 3149043, 21795664.
30. Phipps A, Buist DSM, Malone K, Barlow W, Porter P, Kerlikowske K, O'Meara E, Li C. Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer. Ann Epidemiol 2012, 22:340-348. 3338877, 22366170.
31. Pollan M, Ascunce N, Ederra M, Murillo A, Erdozain N, Ales Martinez J, Pastor Barriuso R. Mammographic density and risk of breast cancer according to tumor characteristics and mode of detection: a Spanish population-based case-control study. Breast Cancer Res 2013, 15:R9. 10.1186/bcr3380, 3672793, 23360535.
32. Ding J, Warren R, Girling A, Thompson D, Easton D. Mammographic density, estrogen receptor status and other breast cancer tumor characteristics. Breast J 2010, 16:279-289. 10.1111/j.1524-4741.2010.00907.x, 20408823.
33. Conroy SM, Pagano I, Kolonel LN, Maskarinec G. Mammographic density and hormone receptor expression in breast cancer: the Multiethnic Cohort Study. Cancer Epidemiol 2011, 35:448-452. 10.1016/j.canep.2010.11.011, 3142304, 21247819.
34. Hinton CP, Roebuck EJ, Williams MR, Blamey RW, Glaves J, Nicholson RI, Griffiths K. Mammographic parenchymal patterns: value as a predictor of hormone dependency and survival in breast cancer. AJR Am J Roentgenol 1985, 144:1103-1107. 10.2214/ajr.144.6.1103, 3873788.
35. Heusinger K, Jud SM, Haberle L, Hack CC, Fasching PA, Meier-Meitinger M, Lux MP, Hagenbeck C, Loehberg CR, Wittenberg T, Rauh C, Wagner F, Uder M, Harmann A, Schulz-Wendtland R, Beckmann MW, Wachter DL. Association of mammographic density with the proliferation marker Ki-67 in a cohort of patients with invasive breast cancer. Breast Cancer Res Treat 2012, 135:885-892. 10.1007/s10549-012-2221-3, 22936391.
36. Morishita M, Ohtsuru A, Hayashi T, Isomoto I, Itoyanagi N, Maeda S, Honda S, Yano H, Uga T, Nagayasu T, Kanematsu T, Yamashita S. Clinical significance of categorisation of mammographic density for breast cancer prognosis. Int J Oncol 2005, 26:1307-1312.
37. Ghosh K, Brandt KR, Sellers TA, Reynolds C, Scott CG, Maloney SD, Carston MJ, Pankratz VS, Vachon CM. Association of mammographic density with the pathology of subsequent breast cancer among postmenopausal women. Cancer Epidemiol Biomarkers Prev 2008, 17:872-879. 10.1158/1055-9965.EPI-07-0559, 2705947, 18398028.
38. Chen JH, Hsu FT, Shih HN, Hsu CC, Chang D, Nie K, Nalcioglu O, Su MY. Does breast density show difference in patients with estrogen receptor-positive and estrogen receptor-negative breast cancer measured on MRI?. Ann Oncol 2009, 20:1447-1449. 10.1093/annonc/mdp362, 2720819, 19654204.
39. Yang WT, Dryden M, Broglio K, Gilcrease M, Dawood S, Dempsey PJ, Valero V, Hortobagyi G, Atchley D, Arun B. Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women. Breast Cancer Res Treat 2008, 111:405-410. 10.1007/s10549-007-9810-6, 18026834.
40. Arora N, King TA, Jacks LM, Stempel MM, Patil S, Morris E, Morrow M. Impact of breast density on the presenting features of malignancy. Ann Surg Oncol 2010, 17(Suppl 3):211-218.
41. Cil T, Fishell E, Hanna W, Sun P, Rawlinson E, Narod SA, McCready DR. Mammographic density and the risk of breast cancer recurrence after breast-conserving surgery. Cancer 2009, 115:5780-5787. 10.1002/cncr.24638, 19902459.
42. Roubidoux MA, Bailey JE, Wray LA, Helvie MA. Invasive cancers detected after breast cancer screening yielded a negative result: relationship of mammographic density to tumor prognostic factors. Radiology 2004, 230:42-48. 10.1148/radiol.2301020589, 14695385.
43. Aiello EJ, Buist DS, White E, Porter PL. Association between mammographic breast density and breast cancer tumor characteristics. Cancer Epidemiol Biomarkers Prev 2005, 14:662-668. 10.1158/1055-9965.EPI-04-0327, 15767347.
44. Fasching P, Heusinger K, Loehberg C, Wenkel E, Lux M, Schrauder M, Koscheck T, Bautz W, Schulz-Wendtland R, Beckmann M, Bani M. Influence of mammographic density on the diagnostic accuracy of tumor size assessment and association with breast cancer tumor characteristics. Eur J Radiol 2006, 60:398-404. 10.1016/j.ejrad.2006.08.002, 17030108.
45. Eriksson L, Hall P, Czene K, Dos Santos Silva I, McCormack V, Bergh J, Bjohle J, Ploner A. Mammographic density and molecular subtypes of breast cancer. Br J Cancer 2012, 107:18-23. 10.1038/bjc.2012.234, 3389424, 22644308.
46. Gierach GL, Lissowska J, Garcia-Closas M, Yang XR, Figuero JD, Anzick S, Wesolowska E, Brinton LA, Meltzer PS, Boyd NF, Sherman ME. Relationship of mammographic density with breast cancer subtypes [Abstract]. American Association for Cancer Research 2010, 2779.
47. Antoni S, Sasco AJ, dos Santos Silva I, McCormack V. Is mammographic density differentially associated with breast cancer according to receptor status? A meta-analysis. Breast Cancer Res Treat 2013, 137:337-347. 10.1007/s10549-012-2362-4, 23239150.
48. Yang X, Figueroa J, Falk R, Zhang H, Pfeiffer R, Hewitt S, Lissowska J, Peplonska B, Brinton L, Garcia Closas M, Sherman M. Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers. Breast Cancer Res 2012, 14:R64. 10.1186/bcr3170, 3446399, 22513288.
49. Ghosh K, Hartmann LC, Reynolds C, Visscher DW, Brandt KR, Vierkant RA, Scott CG, Radisky DC, Sellers TA, Pankratz VS, Vachon CM. Association between mammographic density and age-related lobular involution of the breast. J Clin Oncol 2010, 28:2207-2212. 10.1200/JCO.2009.23.4120, 2860438, 20351335.
50. Razzaghi H, Troester M, Gierach G, Olshan A, Yankaskas B, Millikan R. Mammographic density and breast cancer risk in White and African American Women. Breast Cancer Res Treat 2012, 135:571-580. 10.1007/s10549-012-2185-3, 3734952, 22864770.
51. Gomatam S, Carter R, Ariet M, Mitchell G. An empirical comparison of record linkage procedures. Stat Med 2002, 21:1485-1496. 10.1002/sim.1147, 12185898.
52. Jaro MA. Probabilistic linkage of large public health data files. Stat Med 1995, 14:491-498. 10.1002/sim.4780140510, 7792443.
53. Quantin C, Binquet C, Bourquard K, Pattisina R, Gouyon-Cornet B, Ferdynus C, Gouyon J-B, François AndrÃthomampersa A. Which are the best identifiers for record linkage?. Med Informatics Internet Medicine 2004, 29:221-227.
54. Newman B, Moorman PG, Millikan R, Qaqish BF, Geradts J, Aldrich TE, Liu ET. The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology. Breast Cancer Res Treat 1995, 35:51-60. 10.1007/BF00694745, 7612904.
55. Livasy CA, Perou CM, Karaca G, Cowan DW, Maia D, Jackson S, Tse CK, Nyante S, Millikan RC. Identification of a basal-like subtype of breast ductal carcinoma in situ. Hum Pathol 2007, 38:197-204. 10.1016/j.humpath.2006.08.017, 17234468.
56. O'Brien KM, Cole SR, Tse CK, Perou CM, Carey LA, Foulkes WD, Dressler LG, Geradts J, Millikan RC. Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. Clin Cancer Res 2010, 16:6100-6110. 10.1158/1078-0432.CCR-10-1533, 3029098, 21169259.
57. Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG. Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol 2000, 151:703-714. 10.1093/oxfordjournals.aje.a010265, 10752798.
58. Liberman L, Menell J. Breast imaging reporting and data system (BI-RADS). Radiol Clin North Am 2002, 40:409-430. 10.1016/S0033-8389(01)00017-3, 12117184.
59. Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, Hoover R, Haile R. Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 1995, 87:1622-1629. 10.1093/jnci/87.21.1622, 7563205.
60. Kato I, Beinart C, Bleich A, Su S, Kim M, Toniolo PG. A nested case-control study of mammographic patterns, breast volume, and breast cancer (New York City, NY, United States). CCC Cancer Causes Control 1995, 6:431-438.
61. Thomas D, Carter R, Bush W, Ray R, Stanford J, Lehman C, Daling J, Malone K, Davis S. Risk of subsequent breast cancer in relation to characteristics of screening mammograms from women less than 50 years of age. Cancer Epidemiol Biomarkers Prev 2002, 11:565-571.
62. Cuzick J, Warwick J, Pinney E, Warren RML, Duffy S. Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst 2004, 96:621-628. 10.1093/jnci/djh106, 15100340.
63. Vachon CM, van Gils CH, Sellers TA, Ghosh K, Pruthi S, Brandt KR, Pankratz VS. Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res 2007, 9:217. 10.1186/bcr1829, 2246184, 18190724.
64. Yaffe MJ, Boyd NF, Byng JW, Jong RA, Fishell E, Lockwood GA, Little LE, Tritchler DL. Breast cancer risk and measured mammographic density. Eur J Cancer Prev 1998, 7(Suppl 1):S47-S55.
65. Greenland S, Pearl J, Robins JM. Causal diagrams for epidemiologic research. Epidemiology 1999, 10:37-48. 10.1097/00001648-199901000-00008, 9888278.
66. Weinberg CR, Sandler DP. Randomized recruitment in case-control studies. Am J Epidemiol 1991, 134:421-432.
67. Nielsen T, Hsu F, Jensen K, Cheang M, Karaca G, Hu Z, Hernandez Boussard T, Livasy C, Cowan D, Dressler L, Akslen L, Ragaz J, Gown A, Gilks CB, Van de Rijn M, Perou C. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 2004, 10:5367-5374. 10.1158/1078-0432.CCR-04-0220, 15328174.
68. Martin LJ, Boyd NF. Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence. Breast Cancer Res 2008, 10:201. 10.1186/bcr1831, 2374950, 18226174.
69. Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, Paterson AD. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 2005, 6:798-808. 10.1016/S1470-2045(05)70390-9, 16198986.
70. Vachon CM, Scott CG, Fasching PA, Hall P, Tamimi RM, Li J, Stone J, Apicella C, Odefrey F, Gierach GL, Jud SM Heusinger K, Beckmann MW, Pollan M, Fernandez-Navarro P, Gonzalez-Neira A, Benitez J, Van Gils CH, Lokate M, Onland-Moret NC, Peeters PH, Brown J, Leyland J, Varghese JS, Easton DF, Thompson DJ, Luben RN, Warren RM, Wareham NJ, Loos RJ, et al. Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk. Cancer Epidemiol Biomarkers Prev 2012, 21:1156-1166. 10.1158/1055-9965.EPI-12-0066, 3569092, 22454379.
71. Palmer J, Boggs D, Wise L, Ambrosone C, Adams Campbell L, Rosenberg L. Parity and lactation in relation to estrogen receptor negative breast cancer in African American women. Cancer Epidemiol Biomarkers Prev 2011, 20:1883-1891. 10.1158/1055-9965.EPI-11-0465, 3179178, 21846820.
72. Kwan M, Chen W, Kroenke C, Weltzien E, Beasley J, Nechuta S, Poole E, Lu W, Holmes M, Quesenberry C, Pierce J, Shu X, Caan B. Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project. Breast Cancer Res Treat 2012, 132:729-739. 10.1007/s10549-011-1914-3, 3507508, 22187127.
73. Turkoz FP, Solak M, Petekkaya I, Keskin O, Kertmen N, Sarici F, Arik Z, Babacan T, Ozisik Y, Altundag K. Association between common risk factors and molecular subtypes in breast cancer patients. Breast 2013, 22:344-350. 10.1016/j.breast.2012.08.005, 22981738.
74. Tamimi R, Colditz G, Hazra A, Baer H, Hankinson S, Rosner B, Marotti J, Connolly J, Schnitt S, Collins L. Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer. Breast Cancer Res Treat 2012, 131:159-167. 10.1007/s10549-011-1702-0, 3237947, 21830014.
75. Devi CRB, Tang TS, Corbex M. Incidence and risk factors for breast cancer subtypes in three distinct South-East Asian ethnic groups: Chinese, Malay and natives of Sarawak, Malaysia. Int J Cancer 2012, 131:2869-2877. 10.1002/ijc.27527, 22407763.
76. Rauh C, Faschingbauer F, Haeberle L, Jud SM, Heusinger K, Fasching PA, Goecke TW, Rajakaruna N, Voigt F, Bani MR, Lux MP, Renner SP, Loehberg CR, Hartmann A, Schulz-Wendtland R, Beckmann MW, Bayer CM. Factors influencing breast changes after pregnancy. Eur J Cancer Prev 2012, 3:259-261.